Session 8: Bioengineering to Address Clinical Challenges
Chairs: Stephen Richardson and Tuula Eriksson
Development of an in vitro model of reactive gliosis using stabilized collagen gels with defined and monitored stiffness environments
Owen Davies, Loughborough University
PDGF is a potent osteogenic factor that can be modulated by TNF-alpha and IL-1 in a bioengineered model of skeletal muscle
Wollis Vas, University College London
The development of decellularised cartilage scaffolds as a novel biomimetic implant for the treatment of non-union bone defects
Ahtasham Raza, University of Sheffield
Optical measurement of oxygen concentration in melanoma spheroid and skin engineered models
Leyla Zilic, University of Sheffield
Deepak Kumar, University of Manchester
A Postoperative treatment for Barrett's oesophagus using injectable, self-assembling peptides
